MEDVi is a streamlined telemedicine platform offering access to GLP-1-based therapies, which have gained global acclaim for their efficacy in appetite regulation and metabolic improvement. Through a simple online health assessment and virtual physician consultation, eligible patients receive customized prescriptions compounded for affordability. Medication is delivered directly to their door with ongoing remote monitoring, dose adjustments, and support from healthcare professionals ensuring safety and efficacy throughout the journey.